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Introduction {#sec001}
============

Hair follicle is a self-renewing organ showing cyclicity composed of anagen (growing phase), catagen (regression phase) and telogen (resting phase). The cyclicity of hair follicle indicates the presence of its own stem cells. After discovery of hair follicle stem cells (HFSCs) resided in bulge region, many studies demonstrate that HFSCs play an important role in hair growth cycle as well as epidermal tissue regeneration \[[@pone.0232206.ref001]\].

Stem cells have a specific metabolic signature that is distinguished from the differentiated somatic cells. For example, embryonic stem cells (ESCs) prefer the glycolysis as a major source of energy production. However, during the differentiation process, they undergo the metabolic shift from glycolysis to mitochondrial respiration \[[@pone.0232206.ref002]\]. Supportedly, in induced pluripotent stem cells (iPSCs), cellular reprogramming process resets mitochondrial function to an immature level similar to ESCs \[[@pone.0232206.ref003],[@pone.0232206.ref004]\]. In other example, during the differentiation of HFSCs, mitochondria elongate with more cristae and show higher activity, accompanying with activated aerobic respiration \[[@pone.0232206.ref005]\]. These results indicate that mitochondrial function is important in determination of stem cell characteristics. Despite the importance of mitochondrial function, it is poorly studied whether mitochondrial dysfunction affects hair growth cycle in adult mice.

Crif1 is a mitochondrial protein ([S1 Fig](#pone.0232206.s001){ref-type="supplementary-material"}), which regulates the synthesis and insertion of oxidative phosphorylation (OXPHOS) polypeptides by interacting with mitoribosomal large subunit \[[@pone.0232206.ref006]\]. Several tissue-specific conditional knockout mice show that Crif1 is essential for mitochondrial function in various tissues such as brain, heart and adipose tissues \[[@pone.0232206.ref007],[@pone.0232206.ref008]\]. We have recently reported that targeted deletion of Crif1 in epidermis using K14-Cre results in decrease of keratinocyte proliferation and differentiation due to mitochondrial dysfunction. We have also observed that hair morphogenesis is severely hampered in epidermal specific Crif1 knockout newborn mice (K14-Cre;Crif^fl/fl^) \[[@pone.0232206.ref009]\].

In this study, we established inducible conditional knockout (icKO) mice to investigate the effect of mitochondrial dysfunction on hair growth of adult mice. We generated Crif1 icKO mice using a keratin-14 (K14) promoter for epidermal and hair follicle keratinocytes (K14-CreERT;Crif1^fl/fl^) and a keratin-15 (K15) promoter for HFSCs (K15-CrePR;Crif1^fl/fl^). Hair growth was delayed by Crif1 loss in epidermis and HFSCs. Our data suggest that mitochondrial function is important for the progression of hair growth cycle.

Materials and methods {#sec002}
=====================

Mice {#sec003}
----

Crif1^fl/fl^ mice were generated as previously described \[[@pone.0232206.ref010]\], and were crossed with KRT14-CreERT2 (The Jackson Laboratory, Bar Harbor, Maine) or KRT15-CrePR mice (generously provided by Dr. George Cotsarelis, Philadelphia, PA). For induction of knockout, mice were shaved at P21 and topically treated with 4-hydroxy tamoxifen (4-OHT) or RU486 (Cayman, Item No. 10006317, 200 μl of 5 mg/ml in acetone) during first telogen (P22-P26). And hair growth was examined around P35-P44.

For depilation-induced anagen, RU486 (200 μl of 5 mg/ml in corn oil) was intraperitoneally injected daily for 10 times during 2 weeks (P35-P48). The left back skin were depilated at P49 and right back skin was depilated at P56 using hair removal wax. Hair growth was examined at P63.

All experiments were performed in accordance with institutional guidelines and approved by Chungnam National University institutional animal care and use committee (IRB CNU-00654). Mice were maintained in conventional condition with food and water *ad libitum* and monitored daily to minimize animal suffering. Mice were sacrificed using CO~2~ gas.

Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) {#sec004}
----------------------------------------------------------------------

The back skin tissues were dissected from mice, and then floated on trypsin solution (Thermo Scientific, Rockford, IL) at 4°C overnight. Epidermis was separated from dermis using the fine forcep. Total RNA was isolated using RNA mini kit (Ambion, Austin, TX) and reverse-transcribed with moloney-murine leukaemia virus (M-MLV) reverse transcriptase (ELPIS Biotech, Daejeon, Korea). qRT-PCR was performed on Applied Biosystems StepOne with SYBR Green real-time PCR master mix (Applied Biosystems, Foster City, CA) according to the manufacture's protocol. The relative expression levels of mRNA were determined by the comparative Ct method. The primer sequences were as follows: Crif1 (`5’-GCGAAAGCAGAAGCGAGAAC-3’, 5’-GGCCCTCCGCTCCTTGT-3’`), Actin `(5’-CGATGCCCTGAGGCTCTTT-3’`, `5’-TGGATGCCACAGGATTCCA-3’`).

Histology and immunostaining {#sec005}
----------------------------

Tissue samples were fixed with 10% formaldehyde, embedded in paraffin, and cut into 4-μm-thick sections. Sections were deparaffinized in xylene and then rehydrated by alcohol series. To examine the histology, sections were stained with hematoxylin and eosin (H&E). For immunohistochemistry, sections were first treated with 3% H~2~O~2~ to block the endogenous peroxidase, then incubated with IHC protein block solution (DAKO, Carpinteria, CA). Sections were then reacted with primary antibody at 4°C for overnight, then sequentially reacted with horseradish peroxidase-conjugated secondary antibody (DAKO). After washing, sections were incubated with diaminobenzidine tetrachloride solution and counterstained with Mayer's hematoxylin. For double immunofluorescence staining, sections were incubated with primary antibodies, then incubated with fluorescence-conjugated secondary antibodies (Abcam, Cambridge, UK). Immunofluorescence signal was detected under a fluorescence microscope (Olympus Corporation, Tokyo, Japan). The following primary antibodies were used: Crif1 (Santa Cruz Biotechnology, Santa Cruz, CA), MTCO1 (Abcam), K15 (Abcam), K5 (Santa Cruz Biotechnology, Santa Cruz, CA), AE15 (Thermo Fisher Scientific), AE13 (Abcam), Lgr5 (Thermo Fisher Scientific) and Ki67 (Vector Laboratories, Burlingame, CA).

Flow cytometry {#sec006}
--------------

Preparation of bulge cells and total epidermal keratinocytes from adult mouse back skins was described previously \[[@pone.0232206.ref011]\]. Briefly, epidermis was separated from dermis after trypsin treatment. The collected epidermis was vigorously pipetted and filtered through a cell strainer. After centrifugation, cells were suspended in PBS and stained with antibodies for hair follicle stem cell markers: anti-integrin-α6 (CD49f) antibody directly coupled to PE (BD Biosciences, San Jose, CA), anti-CD34 antibody directly coupled to FITC (BD Biosciences). After washing with PBS, cells were analyzed using FACScaliber (BD Biosciences).

Statistical analysis {#sec007}
--------------------

All experiments were repeated at least three times with separate batches. Data were evaluated statistically using Mann-Whitney test. Statistical significance was set at p\<0.05.

Results {#sec008}
=======

Delayed hair growth cycle by Crif1 loss in epidermis {#sec009}
----------------------------------------------------

We created the epidermal specific inducible conditional knockout (icKO) mice because that K14-Cre;Crif^fl/fl^ mice died within a week after birth. \[[@pone.0232206.ref009]\] We bred K14-CreERT transgenic mice with Crif1^fl/fl^ mice. The resulting K14-CreERT;Crif1^fl/fl^ mice (Crif1 K14icKO) and littermate Crif1^fl/fl^ (WT) mice were topically treated with tamoxifen from P21 for 5 days. At P35, targeted deletion of Crif1 was verified by quantitative-PCR using epidermal lysates ([Fig 1A](#pone.0232206.g001){ref-type="fig"}). In immunohistochemistry, the expression of Crif1 was markedly reduced in Crif1 K14icKO mice. Together, MTCO1 (an mtDNA-encoded subunit of OXPHOS) was remarkably reduced in Crif1 K14icKO mice, indicating that mitochondrial dysfunction was successfully achieved by Crif1 loss ([Fig 1B](#pone.0232206.g001){ref-type="fig"}). After induction of Crif1 loss by tamoxifen treatment, Crif1 K14icKO showed delayed anagen induction compared to WT mice. At P35, the back skin of WT mice was covered with newly grown black hairs (anagen appearance), while the back skin of Crif1 K14icKO mice showed pinkish telogen appearance ([Fig 1C](#pone.0232206.g001){ref-type="fig"}). Histological analysis confirmed that hair follicles were at anagen phase in WT mice while at telogen phase in Crif1 K14icKO mice, evidenced by hair follicle length ([Fig 1D](#pone.0232206.g001){ref-type="fig"}). To examine the proliferative status of hair follicle cells, we performed immunohistochemical staining using Ki67 antibody. The Ki67 positive cells were detected in hair follicles of WT mice, whereas the Ki67 positive cells were barely detected in Crif1 K14icKO mice ([S2 Fig](#pone.0232206.s002){ref-type="supplementary-material"}). These data suggested that hair growth cycle was delayed in Crif1 K14icKO mice.

![Effect of Crif1 deficiency in epidermal cells.\
Crif1^fl/fl^ (WT) mice and K14-CreERT;Crif1^fl/fl^ (Crif1 K14icKO) mice were shaved at P21 (telogen) and topically applied with 4-hydroxy tamoxifen (4-OHT) (1 mg/mice) for 5 days. Hair growth was examined at P35. (A) Total RNAs were isolated from epidermis at P35, and real time RT-PCR was performed (n = 4, \*\*P \< 0.01). (B) Immunohistochemistry for Crif1 and MTCO1 in the epidermis of WT and Crif1 K14icKO mice at P35 (red, Crif1; blue, DAPI). A dotted white line indicates the basement membrane zone. Scale bar, 200 μm. (C) An image showing hair growth after 4-OHT treatment at P35. Anagen induction was delayed in Crif1 K14icKO mice compared to WT mice. (D) Histochemical analysis of skin sections from WT and Crif1 K14icKO mice at P35. Scale bar, 200 μm. Quantification of hair follicle length are represented in bar graph (n = 4, 10--15 hair follicles/mice, \*\*P \< 0.01).](pone.0232206.g001){#pone.0232206.g001}

Delayed hair growth cycle by Crif1 loss in hair follicle stem cells {#sec010}
-------------------------------------------------------------------

During hair growth cycle, telogen-to-anagen transition is associated with activation of HFSCs \[[@pone.0232206.ref012]\]. To examine the role of Crif1 in HFSCs, we created HFSC specific icKO using K15-CrePR mice \[[@pone.0232206.ref013]\]. The K15-CrePR;Crif1^fl/fl^ (Crif1 K15icKO) and littermate Crif1^fl/fl^ (WT) mice were topically treated with RU486 from P21 for 5 days, and then hair growth was analyzed. Hair bulge-specific knockout of Crif1 was verified by immunohistochemical staining ([S3 Fig](#pone.0232206.s003){ref-type="supplementary-material"}). At P44, the back skins of WT and Crif1 K15icKO mice showed similar anagen appearances ([Fig 2A](#pone.0232206.g002){ref-type="fig"}). Histological analysis revealed that all the hair follicles were at fully grown anagen phase in WT mice. However, in Crif1 K15icKO mice, some of hair follicles were at anagen stage (black arrows) but some of hair follicles were very tiny and did not grow to reach the lower fat layer (red arrows) ([Fig 2B](#pone.0232206.g002){ref-type="fig"}). Hair follicle length was significantly shorter in Crif1 K15icKO mice compared to WT mice ([Fig 2C](#pone.0232206.g002){ref-type="fig"}). Similar to Crif1 K14icKO mice, the Ki67 positive cells were significantly decreased in Crif1 K15icKO mice ([S2 Fig](#pone.0232206.s002){ref-type="supplementary-material"}). To investigate the effect of Crif1 knockout on the differentiation of hair follicle cells, we performed immunohistochemical staining using keratin 5 (K5), AE15 and AE13 antibodies to detect ORS, IRS, and hair cortex, respectively. K5 immunoreactivity was observed in basal layer of ORS of both the WT and Crif1 K15icKO mice. As for AE15 and AE13 immunoreactivity, it was also weaker in Crif1 K15icKO mice than WT mice ([Fig 2D](#pone.0232206.g002){ref-type="fig"}). These results suggested that Crif1 loss affected the differentiation of hair follicles cells. We also examined the effect of Crif1 knockout on the differentiation of interfollicular epidermal cells. Immunohistochemical staining for differentiation markers, including loricrin and filaggrin, showed no difference between WT and Crif1 K15icKO mice ([S4 Fig](#pone.0232206.s004){ref-type="supplementary-material"}). These results indicated that conditional knockout of Crif1 in HFSCs did not affect the differentiation of interfollicular epidermal cells.

![Effect of Crif1 deficiency in hair follicle stem cells.\
(A) Crif1^fl/fl^ (WT) mice and K15-CrePR;Crif1^fl/fl^ (Crif1 K15icKO) mice were shaved at P21 and then topically treated with RU486 (1 mg/mice) for 5 days. An image showing hair growth after RU486 induction at P44. (B) Histochemical analysis of skin sections from WT and Crif1 K15icKO mice at P44. In Crif1 K15icKO mice, some hair follicles were at fully grown anagen stage (black arrows), while some hair follicle were very tiny and did not reach to the subcutaneous fat layer (red arrows). Scale bar, 200 μm. (C) Quantification of hair follicle length are represented in bar graph (n = 3, 10--15 hair follicles/mice, \*\*P \< 0.01). (D) Immunohistochemistry for keratin 5 (K5), AE15, and AE13 in WT and Crif1 K15icKO mice at P44. Scale bar, 50 μm.](pone.0232206.g002){#pone.0232206.g002}

To further investigate the effect of Crif1 deficiency on hair growth cycle, we employed depilation-induced anagen model. \[[@pone.0232206.ref014]\] WT mice showed darker skin with new hair growth after depilation in a time-dependent manner, while Crif1 K15icKO mice showed brighter skin with delayed hair growth ([Fig 3A](#pone.0232206.g003){ref-type="fig"}). Histological analysis showed that WT mice displayed mid anagen at 1 week and late anagen at 2 weeks after depilation. However, Crif1 K15icKO mice showed early anagen at 1 week and mid anagen at 2 weeks after depilation ([Fig 3B](#pone.0232206.g003){ref-type="fig"}). Hair follicle length in Crif1 K15icKO mice was significantly shorter than that of WT mice, supporting the delayed hair growth cycle in Crif1 K15icKO mice ([Fig 3C](#pone.0232206.g003){ref-type="fig"}).

![Effect of Crif1 deficiency on depilation-induced anagen.\
(A) Crif1^fl/fl^ (WT) mice and K15-CrePR;Crif1^fl/fl^ (Crif1 K15icKO) mice were intraperitoneally injected with RU486 (1 mg/mice) for 2 weeks (P35-P48) and then hair was plucked at P49 (2 weeks) and P56 (1 week). Hair growth was examined at P63. Compared to WT mice, depilation-induced anagen was retarded in Crif1 K15icKO mice. (B) H&E staining of skin sections from WT and Crif1 K15icKO mice at 1 and 2 weeks after depilation. Scale bar, 200 μm. (C) Quantification of hair follicle length are represented in bar graph (n = 3, 10--15 hair follicles/mice, \*\*P \< 0.01).](pone.0232206.g003){#pone.0232206.g003}

Effect of Crif1 loss on maintenance of hair follicle stem cells {#sec011}
---------------------------------------------------------------

Despite the deficiency of Crif1 in HFSCs, hair growth cycle still progressed in Crif1 K15icKO mice. Thus, we checked whether Crif1 loss affected HFSC maintenance. In immunohistochemistry, K15-positive HFSCs were detected regardless of Crif1 deficiency in hair follicle bulge region of Crif1 K15icKO mice ([Fig 4A](#pone.0232206.g004){ref-type="fig"}). In addition, Lgr5-positive quiescent stem cells were also detected in both the WT and Crif1 K15icKO mice ([S5 Fig](#pone.0232206.s005){ref-type="supplementary-material"}). To characterize further the HFSC status, we carried out flow cytometry analysis using CD34 and integrin-α6 antibodies \[[@pone.0232206.ref015]\]. Results showed that CD34^+^/integrin-α6^+^ HFSCs were maintained in Crif1 K15icKO mice although the cell population was slightly decreased in Crif1 K15icKO mice compared to WT mice ([Fig 4B](#pone.0232206.g004){ref-type="fig"}). These data indicated that Crif1 was not required for maintenance of HFSCs.

![Effect of Crif1 deficiency on maintenance of hair follicle stem cells.\
(A) Crif1^fl/fl^ (WT) mice and K15-CrePR;Crif1^fl/fl^ (Crif1 K15icKO) mice were shaved at P21 and then topically treated with RU486 (1 mg/mice) for 5 days. Skin sections were prepared at P44 and double-stained with K15 (hair follicle stem cell marker) and Crif1 antibodies (red, K15; green, Crif1; blue, DAPI). Scale bar, 200 μm. The number of K15-positive cells per hair follicle was quantified (n = 3, n.s.: not significant). (B) Representative flow cytometry dot plots of epidermal cells labeled with CD34 and integrin-α6 antibodies. The CD34^+^/integrin-α6^+^ cells in WT and Crif1 K15icKO mice were highlighted in red box. Percentages of CD34^+^/integrin-α6^+^ cells (lower left), CD34^+^/integrin-α6^-^ cells (lower middle), and CD34^+^ cells (lower right) are represented in bar graph (n = 3, \*P \< 0.05).](pone.0232206.g004){#pone.0232206.g004}

Discussion {#sec012}
==========

Mitochondria are the important organelles that serve their essential role as the energy-producing center in the cells. In addition to this primary function, a variety of cellular activities are related to mitochondria. For example, imbalance of mitochondrial respiratory chain complexes in the epidermis results in severe inflammatory phenotype with massive immune cell infiltrates \[[@pone.0232206.ref016]\]. In other example, mitochondrial dysfunction leads to delayed wound closure and reduced epidermal thickness together with epidermal stem cell exhaustion in older ages \[[@pone.0232206.ref017]\]. Although the majority of biological events that require energy expenditure are dependent on mitochondrial function, however various cellular events are still taken place in the absence of mitochondria-dependent energy production.

In this study, we examined the effect of mitochondrial dysfunction in terms of Crif1 deficiency on hair growth cycle in adult mice. Our data showed that inducible conditional knockout of Crif1 in epidermis (Crif1 K14icKO) and HFSCs (Crif1 K15icKO) retarded the hair growth cycle. In a previous study, Kloepper et al. has reported that intraepithelial ablation of electron transport chain (ETC) by deletion of mitochondrial transcription factor A (TFAM) delays morphogenesis of hair follicle, probably due to a significantly decreased proliferation rate of K14^+^ cells. Furthermore, intraepithelial ETC ablation affects the epithelial-mesenchymal interactions, resulting in reduction of the inductive capacity of murine hair follicle mesenchyme \[[@pone.0232206.ref018]\]. Thus, it is possible that inducible conditional knockout of Crif1 in epidermis leads to similar defect in epithelial-mesenchymal interactions, thereby affecting the progression of hair growth cycle negatively. Elucidation of precise mechanism underlying retardation of hair growth cycle remains to be clarified.

In this study, Crif1 deficiency did not result in depletion of HFSCs in adult mice. Crif1 deletion using K15-CrePR system resulted in slight but significant reduction of CD34^+^/integrin-α6^+^ cell population ([Fig 4B](#pone.0232206.g004){ref-type="fig"} lower left graph). In contrast, CD34^+^/integrin-α6^-^ cell population increased slightly although there was no statistical significance ([Fig 4B](#pone.0232206.g004){ref-type="fig"} lower middle graph). Since it has been recognized that both the cell populations (CD34^+^/integrin-α6^+^ and CD34^+^/integrin-α6^-^) have same characteristics in terms of self-renewal and multipotency \[[@pone.0232206.ref019]\], eventually there was no difference in number of CD34^+^ HFSCs between WT and Crif1 K15icKO mice ([Fig 4B](#pone.0232206.g004){ref-type="fig"} lower right graph). These results support the idea that mitochondria-dependent energy production is not required for HFSC maintenance. Since it has been well demonstrated that some stem cells including ESCs and iPSCs use the glycolysis to produce energy rather than mitochondrial OXPHOS system \[[@pone.0232206.ref020]\], it is plausible that similar metabolic event is employed by HFSCs. Based on the fact that HFSCs are relatively quiescent, it can be postulated that the glycolysis provides sufficient energy for maintenance of HFSC activity and Crif1 deficiency do not affect the HFSC maintenance critically. Elucidation of precise link between mitochondrial function and HFSC behavior will be an interesting further study.

In summary, we demonstrated that conditional knockout of Crif1 in epidermis and HFSCs retarded hair growth cycle, and that HFSC population was not affected by Crif1 deficiency. Our data suggest that mitochondrial function is important for the progression of hair growth cycle, but not for maintenance of HFSCs.

Supporting information {#sec013}
======================

###### Localization of Crif1 in mitochondria.

Cultured outer root sheath (ORS) cells were co-stained with mitotracker (red) and Crif1 (green). Nucleus was counterstained with 4,6-diamidino-2-phenylindole (DAPI, blue). Scale bar, 20 μm.

(TIF)

###### 

Click here for additional data file.

###### Immunohistochemical staining of proliferative cells in hair follicles.

\(A\) Crif1^fl/fl^ (WT) mice and K14-CreERT;Crif1^fl/fl^ (Crif1 K14icKO) mice were shaved at P21 and topically applied with 4-hydroxy tamoxifen (1 mg/mice) for 5 days. Skin sections were obtained at P35 and stained using Ki67 antibody. (B) Crif1^fl/fl^ mice and K15-CrePR;Crif1^fl/fl^ (Crif1 K15icKO) mice were shaved at P21 and topically treated with RU486 (1 mg/mice) for 5 days. Skin sections were obtained at P44 and stained using Ki67 antibody. Scale bar, 100 μm.

(TIF)

###### 

Click here for additional data file.

###### Crif1^fl/fl^ (WT) mice and K15-CrePR;Crif1^fl/fl^ (Crif1 K15icKO) mice were shaved at P21 and topically treated with RU486 (1 mg/mice) for 5 days.

Skin sections were obtained at P44 and stained using Crif1 antibody. Crif1 immunoreactivity was observed in epidermis of Crif1 K15icKO mice. In contrast, Crif1 immunoreactivity was very weak in hair bulge of Crif1 K15icKO mice. Scale bar, 100 μm (upper), 50 μm (lower).

(TIF)

###### 

Click here for additional data file.

###### Effect of Crif1 conditional knockout on epidermal differentiation.

Crif1^fl/fl^ (WT) mice and K15-CrePR;Crif1^fl/fl^ (Crif1 K15icKO) mice were shaved at P21 and topically treated with RU486 (1 mg/mice) for 5 days. Skin sections were obtained at P44 and stained using loricrin (LOR) and filaggrin (FLG) antibodies. There was no difference in differentiation marker expression between WT and Crif1 K15icKO mice. Scale bar, 100 μm.

(TIF)

###### 

Click here for additional data file.

###### Crif1^fl/fl^ (WT) mice and K15-CrePR;Crif1^fl/fl^ (Crif1 K15icKO) mice were shaved at P21 and topically treated with RU486 (1 mg/mice) for 5 days.

Skin sections were obtained at P44 and stained using Lgr5 antibody. Lgr5 was detected in both the WT and Crif1 K15icKO mice. Scale bar, 50 μm.

(TIF)

###### 

Click here for additional data file.

###### Expression of Crif1 during hair cycle.

Scale bar, 200 μm.

(TIF)

###### 

Click here for additional data file.
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4\. The authors claim that the level of MTCO1 is reduced in Crif1 K14icKO mice, indicating that mitochondrial dysfunction is achieved by Crif1 loss. However, the histology quality need to be improved (at least the image I can see in the pdf). Magnification and better quality images are needed since this is the only evidence for mitochondrial dysfunction. Is MTCO also decreased in the dermal cell as it looks from the image provided (fig.1 and 4)?

5\. It would be very informative to have also a better staining for Crif1 to be able to see if in the adult epidermis Crif1 is present in the mitochondria/cytoplasm or in the nucleus (from literature, a crucial function in mitochondria but also Crif1 can have a transcriptional cofactor role (i.e. Stat3). This will help the interpretation of the result. In addition, a mitochondrial/cytoplasmic expression would support the use of epidermal Crif1cKO as a model to study mitochondrial dysfunction. While a nuclear staining would suggest that the phenotype observed in Crif1 cKO HFs might also be caused by a transcriptional deregulation.

6\. In Velarde et al 2015, the authors showed that mitochondrial dysfunction can have opposite phenotype in skin regeneration. It would be interesting to know if the phenotype observed associated to a deficiency of Crif1 in hair follicle stem cells is age dependent.

7\. Which statistical test has been used to calculate the p values?

Reviewer \#2: This interesting work by Shin et al., show a link of the mitochondrial protein Crif1 with hair follicle cycling. The authors have previously published a study using constitutive K14-Cre driven Crif1 KO, which led to neonatal death. Whereas the current study focuses on inducible KO in adult mice to study hair cycle and hair follicle stem cell (HFSC) maintenance. The authors induce the deletion of Crif1 in the basal layer of epidermis (includes quiescent and proliferating stem cells and transit amplifying cells) using K14-CreERT2 mice and in the hair follicle bulge region (reservoir HFSC) using K15-CrePR mice. Both deletion models yield similar hair cycle phenotype -- i.e., the progression of hair cycle is affected. The authors further analyzed the status of stem cell maintenance and found no obvious stem cell depletion in Crif1-deleted skin. While this study shed light on a crucial role of Crif1 in murine hair cycle, there are few concerns that need to be addressed before the publication of the manuscript in PLoS ONE.

To produce new hairs, existing follicles undergo cyclical bouts of growth (anagen), regression (catagen) and rest (telogen). HFSCs, especially the quiescent populations are activated during telogen to anagen transition phase to start a new round of hair growth. Therefore, hair cycle is a process that intricately dependent of HFSCs. So, it is puzzling why there is no effect of Crif1 deletion on HFSC maintenance despite there is a strong phenotype in hair cycle progression.

The data (Fig. 1, 2 and 3) regarding hair cycle is convincing but the stem cell maintenance part is not. In Fig. 4, the authors show that stem cell depletion is not observed. This conclusion needs further experimental support other than K15 staining and FACS analysis of CD34+ Itga6+ cells. A major concern is that the K15 expression doesn't exclusively report the stem cell populations, rather it labels the whole bulge region which consists of quiescent and proliferative stem cell populations. If quiescent stem cell populations are affected, the authors wouldn't observe it. It would be convincing if they show other bulge stem cell marker expression (such as Lgr5) either by immunohistochemistry or qPCR on CD34+ FACS sorted cells. They could also use CD34+ sorted cells to validate the deletion of Crif1 by qPCR as the immunostaining in Fig. 4A is not convincing. Crif1 staining is almost absent in all compartment of skin, one would expect to lose the expression in bulge region, not in other compartments. This need to be addressed.

In fact, an ideal and elegant experiment to show the HFSC maintenance is EdU-pulse chase to analyze the label retaining cells (LRC). However, this is a time-consuming experiment, which would normally take about 3 months to complete, hence I am not suggesting it here. Instead, the authors should consider showing proliferative state of the epidermis and hair follicles (in both inducible models) by Ki-67 immunostaining.

Other concerns:

1\. Expression dynamics of WT Crif1 must be compared during anagen, catagen and telogen stages. This could be done using qPCR and immunohistochemistry. This data would help to understand the specificity of Crif1 function in hair cycle.

2\. Fig. 1B -- include a higher magnification image of interfollicular epidermis (IFE) expression of Crif1 in WT and icKO to show in which layers the Crif1 is expressed. Similarly, include images for MTCO1 expression as well.

3\. Individual data points must be shown on the error bars of graphs.

4\. In Fig. 1C and 2C -- how many hair follicles per mouse was analysed? This information should be mentioned in the figure legends.

5\. The manuscript would benefit from a minor grammatical revision.

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0232206.r002

Author response to Decision Letter 0

22 Dec 2019

Response to Reviewer

Reviewer \#1: The manuscript by Jung-Min Shin et al. examined the effect of Crif1 genetic loss on hair follicle (HF). The authors showed that in adult skin epidermal specific ablation of Crif1 leads to a delayed anagen induction. A similar phenotype was observed when they ablated Crif1 in K15+ HF stem cells both in physiological telogen-to-anagen transition and also in depilation induced anagen. Finally, since a small reduction of HF stem cells in K15 specific Crif1 Knock out compared to control was found, the authors claimed that Crif1 is not required for maintenance of HF stem cell.

Although these observations are convincing and interesting, the authors should strengthen the manuscript with further analysis, since there are not any mechanistic insights.

Here some suggestions that should be taken in consideration to improve the manuscript:

1\. In a previous paper from the same lab the authors showed the effect of Crif1 epidermal ablation on the differentiation level of developing epidermal cells (Shin et al. Scientific Report 2017). Is differentiation affected in growing bulbs upon Crif1 loss? If so, there is any particularly affected lineage? The authors could check for some markers of differentiated lineage in the bulb (see for example fig1 in Kobielak et al. JCB 2003).

As you suggested, we performed immunohistochemical staining to determine the effect of Crif1 loss on differentiation in hair follicles. We used keratin 5 (K5) antibody for ORS and AE15 antibody for IRS. The K5 immunoreactivity was observed in basal layer of ORS of both the WT and Crif1 K15icKO mice. However, it was likely that K5 immunoreactivity in Crif1 K15icKO mice was slightly weaker than that of WT mice. As for AE15 immunoreactivity, it was also weaker in IRS of Crif1 K15icKO mice than WT mice. These results suggested that Crif1 loss affected the differentiation of epidermal cells in hair follicles. We added new data in revised Fig 2D. We also added the descriptions for Fig 2D in page 10 / line 2 and page 10 / line 22 of revised manuscript.

2\. Reduced proliferation and increased apoptosis were previously detected in Crif1cKO developing epidermis (Shin et al. Scientific Report 2017). In the present inducible system, are HF stem cells less proliferation or a bit more apoptotic in the earlier stages of the telogen-to-anagen transition?

We performed immunohistochemical staining using Ki67 antibody to examine the proliferation of hair follicle cells. The Ki67 positive cells were detected in the hair follicles of WT mice, whereas the Ki67 positive cells were barely detected in both the Crif1 K14icKO mice and Crif1 K15icKO mice (Supplementary Fig S2). When we performed TUNEL staining, we could not detect any difference between WT and inducible conditional knockout mice (data not shown). We added the description for Supplementary Fig S2 in page 8 / line 18 and page 9 / line 24 of revised manuscript.

3\. If a defect in differentiation, proliferation or apoptosis will be detected in HF cells (point 1 and 2), do interfollicular epidermal cells show a similar phenotype? If it is not the case, is this difference due to the fact that HF cells are more dependent on WNT signalling rather than interfollicular epidermal cells?

We examined whether conditional knockout of Crif1 affected the differentiation of interfollicular epidermis. Immunohistochemical staining for epidermal differentiation markers, including loricrin and filaggrin, showed no difference between WT and Crif1 K15icKO mice (Supplementary Fig S4). These results indicated that conditional knockout of Crif1 in HF stem cells did not affect the differentiation of interfollicular epidermal cells. As you pointed out, we think that there is a difference in cells\' responsibility to extracellular signals such as WNT between WT and conditional knockout mice, and this may be a cause for difference in differentiation potential between hair follicle cells and interfollicular epidermal cells. The molecular basis underlying the difference between hair follicle cells and interfollicular epidermal cells remains to be disclosed. We added the description for Supplementary Fig S4 in page 10 / line 8 of revised manuscript.

4\. The authors claim that the level of MTCO1 is reduced in Crif1 K14icKO mice, indicating that mitochondrial dysfunction is achieved by Crif1 loss. However, the histology quality need to be improved (at least the image I can see in the pdf). Magnification and better quality images are needed since this is the only evidence for mitochondrial dysfunction. Is MTCO also decreased in the dermal cell as it looks from the image provided (fig.1 and 4)?

As you suggested, we performed MTCO1 immunostaining again. We changed Fig 1B with new staining data, which showed that expression of MTCO1 was significantly reduced in Crif1 K14icKO mice. As for dermal cell staining, it looked like MTCO1 also decreased as you pointed out. Actually, we performed all staining procedure simultaneously with WT and cKO paraffin blocks, and we did not know exactly the reason why it appeared less stained. We speculated that the difference in extracellular matrix deposition between WT and cKO mice affected the background staining.

5\. It would be very informative to have also a better staining for Crif1 to be able to see if in the adult epidermis Crif1 is present in the mitochondria/cytoplasm or in the nucleus (from literature, a crucial function in mitochondria but also Crif1 can have a transcriptional cofactor role (i.e. Stat3). This will help the interpretation of the result. In addition, a mitochondrial/cytoplasmic expression would support the use of epidermal Crif1cKO as a model to study mitochondrial dysfunction. While a nuclear staining would suggest that the phenotype observed in Crif1 cKO HFs might also be caused by a transcriptional deregulation.

We performed immunohistochemistry and changed Fig 1B, in which Crif1 is mainly detected in cytosol. To further examine the localization of Crif1, we also performed immunocytochemistry using mitotracker and Crif1 antibody in cultured ORS cells. As shown in Supplementary Fig S1, Crif1 co-localized with mitotracker in ORS cells. Thus we think that Crif1 localizes mainly in mitochondria. We added the words 'Supplementary Fig S1' in page 3 / line 19 of revised manuscript.

6\. In Velarde et al 2015, the authors showed that mitochondrial dysfunction can have opposite phenotype in skin regeneration. It would be interesting to know if the phenotype observed associated to a deficiency of Crif1 in hair follicle stem cells is age dependent.

In Velarde\'s paper, Sod2 deficiency accelerated wound closure in young mice (4\~8 month), whereas Sod2 deficiency delayed wound closure in old mice (11\~14 month). In our experiment, we observed phenotype of Crif1 conditional knockout mice at less than 2 months old after birth. Thus, at the moment, we don\'t know if opposite phenotype will occur in old mice. The age-dependent phenotype change in Crif1 mice will be an interesting future study.

7\. Which statistical test has been used to calculate the p values?

We statistically evaluated data using Mann-Whitney test. We added 'statistical analysis' in Materials and methods section (page 7 / line 14).

Reviewer \#2: This interesting work by Shin et al., show a link of the mitochondrial protein Crif1 with hair follicle cycling. The authors have previously published a study using constitutive K14-Cre driven Crif1 KO, which led to neonatal death. Whereas the current study focuses on inducible KO in adult mice to study hair cycle and hair follicle stem cell (HFSC) maintenance. The authors induce the deletion of Crif1 in the basal layer of epidermis (includes quiescent and proliferating stem cells and transit amplifying cells) using K14-CreERT2 mice and in the hair follicle bulge region (reservoir HFSC) using K15-CrePR mice. Both deletion models yield similar hair cycle phenotype -- i.e., the progression of hair cycle is affected. The authors further analyzed the status of stem cell maintenance and found no obvious stem cell depletion in Crif1-deleted skin. While this study shed light on a crucial role of Crif1 in murine hair cycle, there are few concerns that need to be addressed before the publication of the manuscript in PLoS ONE.

To produce new hairs, existing follicles undergo cyclical bouts of growth (anagen), regression (catagen) and rest (telogen). HFSCs, especially the quiescent populations are activated during telogen to anagen transition phase to start a new round of hair growth. Therefore, hair cycle is a process that intricately dependent of HFSCs. So, it is puzzling why there is no effect of Crif1 deletion on HFSC maintenance despite there is a strong phenotype in hair cycle progression.

The data (Fig. 1, 2 and 3) regarding hair cycle is convincing but the stem cell maintenance part is not. In Fig. 4, the authors show that stem cell depletion is not observed. This conclusion needs further experimental support other than K15 staining and FACS analysis of CD34+ Itga6+ cells. A major concern is that the K15 expression doesn't exclusively report the stem cell populations, rather it labels the whole bulge region which consists of quiescent and proliferative stem cell populations. If quiescent stem cell populations are affected, the authors wouldn't observe it. It would be convincing if they show other bulge stem cell marker expression (such as Lgr5) either by immunohistochemistry or qPCR on CD34+ FACS sorted cells. They could also use CD34+ sorted cells to validate the deletion of Crif1 by qPCR as the immunostaining in Fig. 4A is not convincing. Crif1 staining is almost absent in all compartment of skin, one would expect to lose the expression in bulge region, not in other compartments. This need to be addressed.

As you suggested, we purchased Lgr5 monoclonal antibody (OTI2A2) (Thermo Fisher Scientific, Cat\# MA5-25644) and performed immunohistochemistry. As a result, Lgr5 was detected in both the WT and Crif1 K15icKO mice. This result indicated that quiescent stem cell populations were not affected by Crif1 loss. We added the description for Supplementary Fig S5 in page 11 / line 23 of revised manuscript.

Regarding the Crif1 staining, we performed immunohistochemistry again using DAB staining method. As shown in Supplementary Fig S3, Crif1 immunoreactivity was observed in epidermis of Crif1 K15icKO mice. In contrast, Crif1 immunoreactivity was very weak in hair bulge of Crif1 K15icKO mice, indicating that bulge specific Crif1 knockout was achieved. We added the description for Supplementary Fig S3 in page 9 / line 18 of revised manuscript.

In fact, an ideal and elegant experiment to show the HFSC maintenance is EdU-pulse chase to analyze the label retaining cells (LRC). However, this is a time-consuming experiment, which would normally take about 3 months to complete, hence I am not suggesting it here. Instead, the authors should consider showing proliferative state of the epidermis and hair follicles (in both inducible models) by Ki-67 immunostaining.

We performed immunohistochemical staining using Ki67 antibody to examine the proliferation of hair follicle cells. The Ki67 positive cells were detected in the hair follicles of WT mice, whereas the Ki67 positive cells were barely detected in both the Crif1 K14icKO mice and Crif1 K15icKO mice (Supplementary Fig S2). We added the description for Supplementary Fig S2 in page 8 / line 18 and page 9 / line 24 of revised manuscript.

Other concerns:

1\. Expression dynamics of WT Crif1 must be compared during anagen, catagen and telogen stages. This could be done using qPCR and immunohistochemistry. This data would help to understand the specificity of Crif1 function in hair cycle.

We performed immunohistochemical statining using Crif1 antibody during hair cycle of normal mice. As shown in Supplementary Fig S6, Crif1 was detected in almost all cells including epidermal keratinocytes and follicular cells. Particularly, Crif1 expression was higher in morphogenesis and anagen stage (P5-P15) than catagen (P19) and telogen (P21) stage. These results suggest that mitochondrial activity is increased in hair growing stage compared to regression and resting stages.

2\. Fig. 1B -- include a higher magnification image of interfollicular epidermis (IFE) expression of Crif1 in WT and icKO to show in which layers the Crif1 is expressed. Similarly, include images for MTCO1 expression as well.

We performed immunohistochemisty and changed Fig 1B with new data. Crif1 and MTCO1 were expressed in all layers of epidermis.

3\. Individual data points must be shown on the error bars of graphs.

We added individual values in all graphs. (Fig 1A, Fig 1D, Fig 2C, Fig 3C, Fig 4A and Fig 4B).

4\. In Fig. 1C and 2C -- how many hair follicles per mouse was analysed? This information should be mentioned in the figure legends.

We added the number of hair follicles used for analysis in the figure legends (page 9 / line 10, page 10 / line 22, page 11 / line 16)

5\. The manuscript would benefit from a minor grammatical revision.

We checked the grammar using word processor program.
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PONE-D-19-23115R1

Deficiency of Crif1 in hair follicle stem cells retards hair growth cycle in adult mice

PLOS ONE

Dear Dr. Kim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please pay specific attention to comments by reviewer no. 1. It would be helpful if you are able to conduct the proposed experiments in an expeditious manner. If not, could you please reply to the reviewers\' concern in your rebuttal.

We would appreciate receiving your revised manuscript by Mar 21 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Aamir Ahmed

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: (No Response)

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors have adequately addressed most comments raised in the previous round of review however there is still a point that I think it should be taken in consideration.

Since the Crif1 deletion does not lead to a loss of HF stem cells, while some defects of HF differentiation have been observed (AE15 staining), I think that the interpretation of the Crif1 inducible KO phenotype is linked to lower efficiency to produce differentiated HF progenies by the HF stem cells.

In this direction, only the AE15 staining has been performed. I suggest to add the staining for another HF differentiation marker and quantify the result from the two markers.

Minor point:

The sentence in the text about K5 is meaningless: "However, it was likely that K5 immunoreactivity in Crif1 K15icKO mice was slightly weaker than that of WT mice ".

Reviewer \#2: The authors have addressed almost all the concerns I have raised in the first review. They performed experiments to prove that the quiescent cell populations were not affected by Crif1 deletion which further reinforces that Crif1 is dispensable for HFSC. Proliferation assay using Ki67 antibody further validates that the Crif1 deletion impedes the proliferation, thus contributing to hair cycle retardation likely by affecting proliferative stem cell population. The manuscript has been improved well and can be published in PLoS One upon minor revision on following;

Fig 4A -- Add label for DAPI

Fig S2 -- Very difficult to infer Ki67 expression from these images. Quantification must be done. Add label for Ki67 in each image.

Fig S3 -- Area of magnification belongs to lower panel should be indicated in the upper panel.

Fig S4 -- Add label for DAPI in each image.

Fig S5 -- Add label for Lrig1 and DAPI in each image.

Fig S6 -- Add label for Crif1 in each image and indicate its site of expression by arrow.

Individual data points in all graphs -- I meant to include data points (dots) for each replicate, not the "cumulative value". For example, if n=3 is carried out in an experiment, the distribution of each value represented as data points(=dots) should be overlaid on the error bar in a bar graph.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0232206.r004

Author response to Decision Letter 1

18 Mar 2020

Response to Reviewer

Reviewer \#1: The authors have adequately addressed most comments raised in the previous round of review however there is still a point that I think it should be taken in consideration.

Since the Crif1 deletion does not lead to a loss of HF stem cells, while some defects of HF differentiation have been observed (AE15 staining), I think that the interpretation of the Crif1 inducible KO phenotype is linked to lower efficiency to produce differentiated HF progenies by the HF stem cells.

In this direction, only the AE15 staining has been performed. I suggest to add the staining for another HF differentiation marker and quantify the result from the two markers.

As you suggested, we performed additional immunohistochemical staining using AE13 antibody obtained from Abcam (ab16113) to detect hair cortex. AE13 immunoreactivity in Crif1 K15icKO mice was markedly weaker than that of WT mice. This result supported that Crif1 deletion induces defects of hair follicle differentiation. We added new data in revised Fig 2D. We also added the descriptions for Fig 2D in page 10 / line 4, 6 and page 10 / line 23 of revised manuscript.

Minor point:

The sentence in the text about K5 is meaningless: "However, it was likely that K5 immunoreactivity in Crif1 K15icKO mice was slightly weaker than that of WT mice ".

We agreed with your point, and deleted the sentence in revised manuscript.

Reviewer \#2: The authors have addressed almost all the concerns I have raised in the first review. They performed experiments to prove that the quiescent cell populations were not affected by Crif1 deletion which further reinforces that Crif1 is dispensable for HFSC. Proliferation assay using Ki67 antibody further validates that the Crif1 deletion impedes the proliferation, thus contributing to hair cycle retardation likely by affecting proliferative stem cell population. The manuscript has been improved well and can be published in PLoS One upon minor revision on following;

Fig 4A -- Add label for DAPI

We added label for DAPI in Fig 4A.

Fig S2 -- Very difficult to infer Ki67 expression from these images. Quantification must be done. Add label for Ki67 in each image.

We quantified Ki67 positive cells and added graphs. We also added label for Ki67 in each image of Fig S2.

Fig S3 -- Area of magnification belongs to lower panel should be indicated in the upper panel.

We marked area of magnification in the upper panel of Fig S3.

Fig S4 -- Add label for DAPI in each image.

We added label for DAPI in Fig S4.

Fig S5 -- Add label for Lrig1 and DAPI in each image.

We added label for Lrig1 and DAPI in Fig S5.

Fig S6 -- Add label for Crif1 in each image and indicate its site of expression by arrow.

We added label for Crif1 and indicated expression of Crif1 by arrow in Fig S6.

Individual data points in all graphs -- I meant to include data points (dots) for each replicate, not the "cumulative value". For example, if n=3 is carried out in an experiment, the distribution of each value represented as data points(=dots) should be overlaid on the error bar in a bar graph.

As your comments, we changed all graphs including data points. (Fig 1A, Fig1D, Fig 2C, Fig 3C, Fig 4A and Fig 4B)
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Deficiency of Crif1 in hair follicle stem cells retards hair growth cycle in adult mice

PONE-D-19-23115R2

Dear Dr. Kim,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Aamir Ahmed

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

10.1371/journal.pone.0232206.r006
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, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
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PONE-D-19-23115R2

Deficiency of Crif1 in hair follicle stem cells retards hair growth cycle in adult mice

Dear Dr. Kim:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.
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